Loading clinical trials...
Loading clinical trials...
Investigations of Dementia in Parkinson Disease
The purpose of this study is to use a brain imaging method called PIB PET to determine dementia subtypes in patients with Parkinson's disease. The ultimate goal of this project is to be able to identify individuals with PD who are at risk of developing dementia, and to distinguish the underlying cause of dementia.
The purpose of this study is to use a brain imaging method called PIB PET to determine dementia subtypes in patients with Parkinson's disease. The ultimate goal of this project is to be able to identify individuals with PD who are at risk of developing dementia, and to distinguish the underlying cause of dementia. We will be including both PD and normal subjects in this study. This a long term study and we are considering including a total of 320 participants in this protocol.
Age
50 - No limit years
Sex
ALL
Healthy Volunteers
Yes
NeuroClinical Research Unit (NCRU), Washington University School of Medicine
St Louis, Missouri, United States
Start Date
August 1, 2006
Primary Completion Date
July 1, 2030
Completion Date
July 1, 2030
Last Updated
July 18, 2025
320
ESTIMATED participants
Lead Sponsor
Washington University School of Medicine
NCT07310264
NCT02119611
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07216976